Binacil 125 mg and 250 mg TABLET,
PDF Leaflet Revision Date: 26 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of fungal infections of the skin and onychomycosis.
Dosage (summary)
250 mg once daily; duration varies by infection type.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; excreted in breast milk.
Key Drug Interactions
- Rifampicin (induces metabolism)
- Cimetidine (inhibits metabolism)
- Oral contraceptives (may cause menstrual disturbances)
Contraindications
- Hypersensitivity to terbinafine
- Impaired liver function
- Pregnancy
- Lactation
Common side effects
- Headache
- Nausea
- Loss of appetite
- Dizziness
- Rash
Counselling Points
- Monitor for liver function
- Avoid in pregnancy and breastfeeding
- Report any signs of liver dysfunction
Serious warnings
- Risk of hepatotoxicity
- May exacerbate psoriasis
- Discontinue if progressive skin rash occurs
Important Disclaimer
The Binacil 125 mg and 250 mg TABLET, professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
